
Keywords: urinary bladder neoplasms; neoadjuvant therapy; perioperative period; treatment outcome; DM; diabetes mellitus; HLOS; hospital length of stay; MI; myocardial infarction; MVAC; methotrexate, vinblastine, doxorubicin and cisplatin; NAC; neoadjuvant chemothe